 Kelly Sullivan
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 17 | 2024 | 483 | 2.650 |
Why?
| | Tumor Suppressor Protein p53 | 11 | 2023 | 527 | 2.090 |
Why?
| | Proteome | 4 | 2024 | 471 | 1.080 |
Why?
| | Apoptosis | 14 | 2023 | 2551 | 0.880 |
Why?
| | Liposarcoma | 1 | 2023 | 27 | 0.810 |
Why?
| | Transcriptome | 6 | 2024 | 966 | 0.780 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 66 | 0.750 |
Why?
| | Interferons | 5 | 2023 | 195 | 0.750 |
Why?
| | Genes, p53 | 2 | 2012 | 68 | 0.740 |
Why?
| | Piperazines | 5 | 2022 | 345 | 0.730 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.680 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.680 |
Why?
| | Transcriptional Activation | 3 | 2022 | 376 | 0.680 |
Why?
| | Azetidines | 1 | 2020 | 44 | 0.670 |
Why?
| | Nuclear Proteins | 6 | 2017 | 707 | 0.650 |
Why?
| | Databases, Genetic | 1 | 2021 | 241 | 0.650 |
Why?
| | Neoplasms | 8 | 2023 | 2687 | 0.620 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2009 | 27 | 0.610 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 322 | 0.570 |
Why?
| | Metabolome | 1 | 2021 | 352 | 0.560 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 82 | 0.550 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 65 | 0.540 |
Why?
| | Hypersensitivity | 1 | 2020 | 254 | 0.540 |
Why?
| | Sulfonamides | 1 | 2020 | 505 | 0.520 |
Why?
| | Histones | 4 | 2009 | 632 | 0.500 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1395 | 0.490 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 907 | 0.480 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 2152 | 0.470 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 212 | 0.470 |
Why?
| | Isoquinolines | 1 | 2015 | 45 | 0.460 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 5 | 0.460 |
Why?
| | Immunity, Innate | 2 | 2020 | 825 | 0.440 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1473 | 0.390 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 2 | 2009 | 9 | 0.380 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 617 | 0.380 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 42 | 0.370 |
Why?
| | RNA, Messenger | 3 | 2020 | 2815 | 0.370 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 627 | 0.360 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 72 | 0.360 |
Why?
| | Patient Selection | 1 | 2015 | 680 | 0.350 |
Why?
| | Fibroblasts | 1 | 2016 | 1002 | 0.350 |
Why?
| | Imidazoles | 3 | 2020 | 239 | 0.340 |
Why?
| | Interferon-alpha | 3 | 2020 | 195 | 0.340 |
Why?
| | Cerebellar Neoplasms | 2 | 2022 | 161 | 0.310 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1746 | 0.310 |
Why?
| | Medulloblastoma | 2 | 2022 | 201 | 0.310 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 121 | 0.290 |
Why?
| | Membrane Proteins | 1 | 2015 | 1149 | 0.290 |
Why?
| | Trisomy | 2 | 2019 | 74 | 0.280 |
Why?
| | Signal Transduction | 7 | 2024 | 5091 | 0.270 |
Why?
| | Drosophila Proteins | 1 | 2009 | 201 | 0.270 |
Why?
| | Pyrimidines | 2 | 2024 | 472 | 0.260 |
Why?
| | Humans | 41 | 2024 | 138969 | 0.260 |
Why?
| | HCT116 Cells | 3 | 2017 | 80 | 0.260 |
Why?
| | Biomarkers | 3 | 2022 | 4095 | 0.250 |
Why?
| | Inflammation | 1 | 2017 | 2853 | 0.250 |
Why?
| | Animals | 18 | 2024 | 37242 | 0.230 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 26 | 0.220 |
Why?
| | Erythropoiesis | 1 | 2024 | 56 | 0.220 |
Why?
| | Datasets as Topic | 2 | 2022 | 125 | 0.220 |
Why?
| | Cell Proliferation | 7 | 2023 | 2480 | 0.210 |
Why?
| | Heme | 1 | 2024 | 77 | 0.210 |
Why?
| | Proto-Oncogene Proteins | 4 | 2023 | 621 | 0.210 |
Why?
| | Autophagy | 2 | 2018 | 286 | 0.210 |
Why?
| | Receptors, Interferon | 2 | 2023 | 52 | 0.210 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 21 | 0.210 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 43 | 0.200 |
Why?
| | Mice | 12 | 2024 | 17827 | 0.200 |
Why?
| | Glutamine | 1 | 2023 | 104 | 0.200 |
Why?
| | Piperidines | 1 | 2024 | 216 | 0.200 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.200 |
Why?
| | Centrosome | 2 | 2023 | 71 | 0.190 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 159 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 442 | 0.190 |
Why?
| | Purines | 2 | 2020 | 179 | 0.190 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 3397 | 0.190 |
Why?
| | Blood | 1 | 2022 | 113 | 0.180 |
Why?
| | Hedgehog Proteins | 2 | 2023 | 199 | 0.180 |
Why?
| | Autoimmunity | 3 | 2024 | 904 | 0.170 |
Why?
| | Cilia | 2 | 2023 | 172 | 0.170 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.170 |
Why?
| | Cell Death | 1 | 2022 | 375 | 0.170 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.170 |
Why?
| | Pyrazoles | 2 | 2022 | 425 | 0.170 |
Why?
| | RNA Interference | 2 | 2015 | 468 | 0.160 |
Why?
| | Data Mining | 1 | 2021 | 116 | 0.160 |
Why?
| | Cytokines | 4 | 2024 | 2083 | 0.160 |
Why?
| | Cell Line | 5 | 2021 | 2879 | 0.160 |
Why?
| | RNA Helicases | 1 | 2020 | 30 | 0.160 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 189 | 0.160 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1471 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2022 | 3574 | 0.150 |
Why?
| | DNA Repair | 1 | 2021 | 229 | 0.150 |
Why?
| | Protein Domains | 2 | 2017 | 289 | 0.150 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2925 | 0.150 |
Why?
| | Kynurenine | 1 | 2019 | 115 | 0.150 |
Why?
| | Metabolomics | 2 | 2021 | 689 | 0.150 |
Why?
| | Complement System Proteins | 2 | 2021 | 319 | 0.140 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 17 | 0.140 |
Why?
| | Proteomics | 2 | 2023 | 1112 | 0.140 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 56 | 0.140 |
Why?
| | RNA Precursors | 2 | 2009 | 154 | 0.140 |
Why?
| | Cell Cycle | 2 | 2012 | 593 | 0.140 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 43 | 0.130 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 434 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 416 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 193 | 0.130 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.130 |
Why?
| | Hypoxia | 1 | 2024 | 1148 | 0.130 |
Why?
| | Caspases | 2 | 2015 | 245 | 0.130 |
Why?
| | Female | 13 | 2024 | 74015 | 0.130 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 97 | 0.130 |
Why?
| | Young Adult | 4 | 2024 | 13371 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.130 |
Why?
| | Antigens | 1 | 2018 | 356 | 0.130 |
Why?
| | Down-Regulation | 2 | 2017 | 636 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 190 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 430 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 176 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5800 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 247 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 159 | 0.120 |
Why?
| | Genomics | 1 | 2021 | 797 | 0.120 |
Why?
| | Male | 9 | 2024 | 68250 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 850 | 0.120 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 11 | 0.110 |
Why?
| | Pyrones | 1 | 2015 | 10 | 0.110 |
Why?
| | Caspase 8 | 1 | 2015 | 48 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 56 | 0.110 |
Why?
| | Cells, Cultured | 3 | 2018 | 4182 | 0.110 |
Why?
| | Adult | 7 | 2024 | 38393 | 0.110 |
Why?
| | Azepines | 1 | 2015 | 97 | 0.110 |
Why?
| | Transcription Factors | 2 | 2022 | 1701 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2017 | 423 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2018 | 737 | 0.110 |
Why?
| | Morpholines | 1 | 2015 | 124 | 0.110 |
Why?
| | Child, Preschool | 4 | 2024 | 11157 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 393 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 142 | 0.110 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.110 |
Why?
| | Fluorouracil | 1 | 2015 | 204 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 236 | 0.100 |
Why?
| | Base Sequence | 3 | 2020 | 2176 | 0.100 |
Why?
| | Monocytes | 1 | 2016 | 573 | 0.100 |
Why?
| | Naphthalenes | 1 | 2013 | 58 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 637 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2015 | 819 | 0.100 |
Why?
| | Ligands | 1 | 2015 | 666 | 0.100 |
Why?
| | Genes, Synthetic | 1 | 2012 | 14 | 0.100 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 626 | 0.090 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 862 | 0.090 |
Why?
| | Liver | 1 | 2020 | 1806 | 0.090 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 203 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1804 | 0.090 |
Why?
| | Telomerase | 1 | 2013 | 247 | 0.090 |
Why?
| | Child | 5 | 2024 | 21935 | 0.090 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 328 | 0.090 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2159 | 0.080 |
Why?
| | Lipids | 1 | 2015 | 675 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2591 | 0.080 |
Why?
| | Hematopoiesis | 2 | 2021 | 193 | 0.080 |
Why?
| | Adolescent | 4 | 2024 | 21581 | 0.080 |
Why?
| | Cleavage Stimulation Factor | 1 | 2009 | 4 | 0.080 |
Why?
| | Endonucleases | 1 | 2008 | 32 | 0.070 |
Why?
| | Infant | 2 | 2024 | 9576 | 0.070 |
Why?
| | Mitochondria | 1 | 2015 | 958 | 0.070 |
Why?
| | Exoribonucleases | 1 | 2008 | 47 | 0.070 |
Why?
| | Mutation | 3 | 2015 | 3984 | 0.070 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2008 | 90 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 329 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1985 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 168 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 232 | 0.070 |
Why?
| | Middle Aged | 3 | 2024 | 33782 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 608 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2283 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2533 | 0.060 |
Why?
| | HeLa Cells | 3 | 2013 | 638 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 62 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 210 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 97 | 0.050 |
Why?
| | Autoantigens | 1 | 2006 | 422 | 0.050 |
Why?
| | Phenotype | 2 | 2023 | 3143 | 0.050 |
Why?
| | Proline | 1 | 2023 | 76 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 29 | 0.050 |
Why?
| | Centrioles | 1 | 2023 | 44 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 85 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 67 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 44 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2233 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 31 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 1317 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2024 | 450 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 165 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 45 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 249 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 324 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 24 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 36 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 8 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2023 | 4316 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 147 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 25 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 57 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 145 | 0.040 |
Why?
| | Gene Silencing | 1 | 2020 | 196 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 36 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 87 | 0.040 |
Why?
| | Phosphorylation | 1 | 2022 | 1767 | 0.040 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 26 | 0.030 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 13 | 0.030 |
Why?
| | Hexokinase | 1 | 2017 | 18 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 403 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2019 | 190 | 0.030 |
Why?
| | Cell Lineage | 1 | 2019 | 350 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2017 | 50 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 505 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2017 | 123 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1457 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 614 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 13 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 433 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 30 | 0.030 |
Why?
| | Gene Editing | 1 | 2017 | 84 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 376 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2017 | 232 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 386 | 0.030 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 131 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 787 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 70 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 956 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1657 | 0.030 |
Why?
| | Glycolysis | 1 | 2017 | 320 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1192 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1148 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 55 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 134 | 0.030 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 39 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1487 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 969 | 0.030 |
Why?
| | Serine Proteases | 1 | 2013 | 19 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1810 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 944 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 910 | 0.030 |
Why?
| | Protein Transport | 1 | 2014 | 443 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 966 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 368 | 0.020 |
Why?
| | Chromatin | 1 | 2016 | 515 | 0.020 |
Why?
| | Telomere-Binding Proteins | 1 | 2013 | 121 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 870 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 1994 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2228 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1229 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1126 | 0.020 |
Why?
| | Ribonucleoprotein, U7 Small Nuclear | 1 | 2008 | 1 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 2008 | 27 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2008 | 16 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2008 | 92 | 0.020 |
Why?
| | Nucleotides | 1 | 2008 | 128 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 385 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 180 | 0.020 |
Why?
| | RNA Stability | 1 | 2008 | 112 | 0.020 |
Why?
| | RNA | 1 | 2014 | 925 | 0.020 |
Why?
| | Drosophila | 1 | 2008 | 152 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2006 | 336 | 0.010 |
Why?
| | Genotype | 1 | 2006 | 1849 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1441 | 0.010 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|